NCT04581174

Brief Summary

The study examines the severity of extraesophageal reflux using oropharyngeal pH monitoring in patients with varying degrees of lower turbinates hypertrophy.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2020

Geographic Reach
2 countries

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 9, 2020

Completed
6 days until next milestone

Study Start

First participant enrolled

October 15, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2021

Completed
Last Updated

December 7, 2022

Status Verified

December 1, 2022

Enrollment Period

12 months

First QC Date

October 2, 2020

Last Update Submit

December 6, 2022

Conditions

Keywords

Inferior nasal turbinate hypertrophyExtraesophageal refluxOropharyngeal pH monitoringRestech system

Outcome Measures

Primary Outcomes (1)

  • Severity of extraesophageal reflux using oropharyngeal pH monitoring

    The primary outcome measure of the study is to examine the severity of extraesophageal reflux using oropharyngeal pH monitoring in patients with varying degrees of lower turbinates hypertrophy, assessed on the RYAN score.

    24 hours

Study Arms (4)

1st degree of hypertrophy according to Camacho

EXPERIMENTAL

Patients with 1st degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values \<5.5 will be evaluated.

Diagnostic Test: 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values <5.5 will be evaluated

2nd degree of hypertrophy according to Camacho

EXPERIMENTAL

Patients with 2nd degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values \<5.5 will be evaluated.

Diagnostic Test: 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values <5.5 will be evaluated

3rd degree of hypertrophy according to Camacho

EXPERIMENTAL

Patients with 3rd degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values \<5.5 will be evaluated.

Diagnostic Test: 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values <5.5 will be evaluated

4th degree of hypertrophy according to Camacho

EXPERIMENTAL

Patients with 4th degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values \<5.5 will be evaluated.

Diagnostic Test: 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values <5.5 will be evaluated

Interventions

Patients with the 1st degree of hypertrophy according to Camacho, 2nd degree of hypertrophy according to Camacho, 3rd degree of hypertrophy according to Camacho, 4th degree of hypertrophy according to Camacho will undergo 24-hour monitoring of oropharyngeal pH by Restech, RYAN scores upright and supine, and pH values \<5.5 will be evaluated.

1st degree of hypertrophy according to Camacho2nd degree of hypertrophy according to Camacho3rd degree of hypertrophy according to Camacho4th degree of hypertrophy according to Camacho

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18-80 years
  • patients indicated for oropharyngeal pH-metry (Restech) with suspected extraesophageal reflux
  • patients with 2nd - 4th degree hypertrophy of the lower turbinates (according to Camacho Classification)

You may not qualify if:

  • patients with chronic rhinosinusitis with polyps
  • patients who have had an acute upper respiratory tract infection in the last 8 weeks
  • patients after previous surgery in the nasal cavity and nasopharynx
  • patients after radiotherapy in the head and neck area
  • non tolerance of pH catheter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, 70852, Czechia

Location

Fortmedica Prague

Prague, 14300, Czechia

Location

Comenius University, University Hospital Bratislava

Bratislava, 85107, Slovakia

Location

Related Publications (7)

  • Camacho M, Zaghi S, Certal V, Abdullatif J, Means C, Acevedo J, Liu S, Brietzke SE, Kushida CA, Capasso R. Inferior turbinate classification system, grades 1 to 4: development and validation study. Laryngoscope. 2015 Feb;125(2):296-302. doi: 10.1002/lary.24923. Epub 2014 Sep 12.

    PMID: 25215619BACKGROUND
  • Farmer SE, Eccles R. Chronic inferior turbinate enlargement and the implications for surgical intervention. Rhinology. 2006 Dec;44(4):234-8.

    PMID: 17216738BACKGROUND
  • Camacho M, Zaghi S, Certal V, Abdullatif J, Modi R, Sridhara S, Tolisano AM, Chang ET, Cable BB, Capasso R. Predictors of Nasal Obstruction: Quantification and Assessment Using Multiple Grading Scales. Plast Surg Int. 2016;2016:6945297. doi: 10.1155/2016/6945297. Epub 2016 May 16.

    PMID: 27293885BACKGROUND
  • Ayazi S, Lipham JC, Hagen JA, Tang AL, Zehetner J, Leers JM, Oezcelik A, Abate E, Banki F, DeMeester SR, DeMeester TR. A new technique for measurement of pharyngeal pH: normal values and discriminating pH threshold. J Gastrointest Surg. 2009 Aug;13(8):1422-9. doi: 10.1007/s11605-009-0915-6. Epub 2009 May 7.

    PMID: 19421822BACKGROUND
  • Chheda NN, Seybt MW, Schade RR, Postma GN. Normal values for pharyngeal pH monitoring. Ann Otol Rhinol Laryngol. 2009 Mar;118(3):166-71. doi: 10.1177/000348940911800302.

    PMID: 19374146BACKGROUND
  • Wiener GJ, Tsukashima R, Kelly C, Wolf E, Schmeltzer M, Bankert C, Fisk L, Vaezi M. Oropharyngeal pH monitoring for the detection of liquid and aerosolized supraesophageal gastric reflux. J Voice. 2009 Jul;23(4):498-504. doi: 10.1016/j.jvoice.2007.12.005. Epub 2008 May 12.

    PMID: 18468849BACKGROUND
  • Zelenik K, Matousek P, Formanek M, Urban O, Kominek P. Patients with chronic rhinosinusitis and simultaneous bronchial asthma suffer from significant extraesophageal reflux. Int Forum Allergy Rhinol. 2015 Oct;5(10):944-9. doi: 10.1002/alr.21560. Epub 2015 Jun 5.

    PMID: 26046448BACKGROUND

MeSH Terms

Interventions

Supine Position

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Karol Zeleník, Ass.Prof.,MD,PhD

    University Hospital Ostrava

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
No masking is being used in this study
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: The study subjects will be enrolled to a total of four study arms, depending on the degree of inferior turbinates hypertrophy (according to Camacho)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2020

First Posted

October 9, 2020

Study Start

October 15, 2020

Primary Completion

September 30, 2021

Study Completion

October 30, 2021

Last Updated

December 7, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Individual participant data may be made available to other researchers upon request.

Locations